This lack of correlation between ERCC1 mRNA expression and the corresponding protein expression might explain the contrasting results on the predictive role of ERCC1 in response to DDP-based therapy in different tumor types, and further underlines the need for validated assays to identify predictive biomarkers. The gene discussed is ERCC1; the disease is neoplasm.